Journal of Family Medicine

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

Family Medicine-Epigenomics and pharmacogenomics in anti-cancer chemotherapy-Shiwei Duan


Ph.D., Professor,
Vice Director of Zhejiang Provincial Key Laboratory,
Pathophysiology School of Medicine, 
Ningbo University, 


Send an Email

Shiwei Duan


Vice Director of Zhejiang Provincial Key Laboratory of Pathophysiology,
School of Medicine, 
Ningbo University, 

Research Interests:

  • Epigenomics and pharmacogenomics in anti-cancer chemotherapy
  • (Epi)Genetics and (epi)genomics for cancers and complex diseases


  • Shiwei Duan, Ph.D. (2005, Molecular Cell Biology, Shanghai Jiao Tong University).
  • Dr. Duan is currently Professor of School of Medicine at Ningbo University.
  • He was born in Wuhan, China.
  • He received his Bachelor (Biochemistry) and Master (Applied Biochemistry) degrees from East China University of Science and Technology in 1997 and 2002.
  • And he received Ph.D. of Molecular Cell biology from Shanghai Jiao Tong University in 2005. Since then, He has held research appointments at School of Medicine at University of Chicago in the United States and Singapore Institute of Clinical Sciences at Agency for Science, Technology and Research (A*STAR) in Singapore, and has taught at School of Medicine of Ningbo University (since 2011).
  • His research interests focus on (Epi)genetics and (Epi)genomics for human complex diseases.